08.07.2020 • NewsCortevaElaine Burridgeagroscience

Corteva Takes Control of PhytoGen Seed

Corteva Agriscience has agreed to take over J.G. Bosell’s stake in their joint-venture company PhytoGen Seed Co. Financial terms of the deal were not disclosed.

PhytoGen Seed was formed in 1998 to focus on the US cottonseed industry with one of Corteva’s predecessors, Dow AgroSciences, owning a 53.5% stake. More recently, Corteva has operated the jv in the US market through wholly owned subsidiary Mycogen.

“This acquisition provides a solid proof point of our consistent commitment to driving long-term growth through targeted investments in solid margin opportunities that at the same time strengthen our ability to serve our customers,” said James Collins, Jr,  CEO of Corteva Agriscience.

Steve Reno, president of the Corteva Seed Business Platform, added: “This step further strengthens Corteva Agriscience’s commitment to the cotton market – and positions the Company well to diversify and grow this business globally over time.”

Corteva said the PhytoGen portfolio, including PhytoGen Breeding Traits, PhytoGen varieties with both the Enlist cotton trait and WideStrike and WideStrike 3 insect protection, is well suited to help farmers protect their crops from potential yield-robbing pests.

Corteva Agriscience has agreed to take over J.G. Bosell’s stake in their...
Corteva Agriscience has agreed to take over J.G. Bosell’s stake in their joint-venture company PhytoGen Seed Co. Owning a 53.5% stake. Corteva has operated the jv in the US market through wholly owned subsidiary Mycogen. Financial terms were not disclosed. (c) Corteva

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.